This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Biologics constitute a majority of the top selling drugs and represent one of the fastest growing segments of the overall pharmaceutical industry. In fact, the share of biologics in the overall pharmaceutical contractmanufacturing market has increased from 16% in 2006 to over 25% in 2017.
The onset of the COVID-19 pandemic has contributed greatly to the increasing demand of oligonucleotide-based products, consequently, proposing lucrative opportunities for custom / contract service providers engaged in this domain. The overall manufacturing of oligonucleotides involves the following steps. Web: [link].
The current landscape consists of more than 95 players that claim to offer oligonucleotide contractmanufacturing services for research, diagnostic and therapeutic applications. These contract service providers are actively entering into strategic collaborations to augment their existing portfolios. Our Social Media Platform.
Pharmaceutical solid dosage forms are the most popular in the pharmaceutical industry and are one of the most used drugdelivery methods across patient groups. Find the leading pharmaceutical solid dose manufacturing companies in contract marketing.
Over the last decade, one of the major challenges faced by pharmaceutical players across the globe is low drug solubility. In fact, it has been observed that around 40% of the pharmaceutical products approved by regulatory organizations exhibit poor bioavailability / solubility. Nanoparticles ContractManufacturing.
The key applications of mRNAs are below: ContractManufacturing in mRNA Synthesis AND Manufacturing Service Domain The synthesis and manufacturing process of mRNA-based therapeutics / vaccines is complex and associated with several challenges.
CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (“ XPhyto ” or the “ Company “) is pleased to announce its drug formulation and delivery business strategy and milestones for 2021. Pending positive results, the Company plans to advance the products toward a final pivotal study and application for regulatory approval.
In fact, over 8,000 biological pharmaceutical products are currently under clinical investigation worldwide. . Biopharmaceutical Excipient Manufacturing Market. Biopharmaceutical Excipient Manufacturing Market. Diverse Landscape of Biopharmaceutical Excipient Manufacturers. Company Competitiveness Analysis.
In fact, over 8,000 biological pharmaceutical products are currently under clinical investigation worldwide. However, for some of the biopharmaceutical excipients, such as lipids, the associated manufacturing processes are highly complex, capital-intensive and fraught with multiple challenges. Our Social Media Platform. Web: [link].
Players Offering Liposome Development and Manufacturing Services Presently, over 70 companies are actively engaged in offering services related to liposomes development and manufacturing, worldwide. Further, most of the liposome development and manufacturing service providers (68%) offer services for discovery / research purposes.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content